New Jersey 2022-2023 Regular Session

New Jersey Senate Bill S4127

Introduced
11/30/23  
Refer
11/30/23  

Caption

Extends certain pay parity regarding telemedicine and telehealth for one year.

Impact

If enacted, S4127 will maintain and fortify the financial structure that supports the delivery of telemedicine and telehealth services in New Jersey. By mandating that reimbursable rates for these services equal those for traditional in-person consultations, the bill aims to promote wider accessibility and acceptance of digital healthcare options, which have proven especially valuable during the COVID-19 pandemic. Additionally, the legislation will continue to ensure that the standard of care for telehealth reflects that of in-person consultations, thus providing safeguards for patient treatment outcomes.

Summary

Senate Bill S4127 aims to extend the existing pay parity regulations for telemedicine and telehealth services for an additional year. This legislation ensures that health carriers offering plans in New Jersey must provide coverage for telehealth and telemedicine services at the same reimbursement rates as those for in-person consultations, thereby addressing the increasing reliance on digital healthcare solutions without compromising on financial equity between service delivery modes. The bill amends previous mandates established in P.L.2017, c.117 and P.L.2021, c.310, which helped lay the foundation for telehealth regulations.

Sentiment

The sentiment surrounding S4127 appears predominantly positive, with supporters touting its necessity for adapting the healthcare system to evolving technologies and patient needs. Advocates believe that the extension of pay parity is critical for encouraging providers to offer telehealth services, which can enhance patient access, particularly for those in underserved or rural areas. While there are no significant opposition voices highlighted in the available discussions, the debate primarily centers on the sustainability of funding and the adaptability of insurance plans to efficiently integrate these services.

Contention

The main points of contention focus on the implementation and sustainability of the pay parity model as telehealth services expand. Concerns about the potential financial burden on insurance providers exist, along with questions regarding the equitable distribution of resources to ensure adequate telehealth service provision. Furthermore, there may be future discussions around whether restrictions imposed by the State Health Benefits Commission on provider networks and coverage limits could eventually impact the access patients have to sought-after telehealth services.

Companion Bills

NJ A5757

Same As Extends certain pay parity regarding telemedicine and telehealth for one year.

Previously Filed As

NJ A4357

Extends permanently certain pay parity regarding telemedicine and telehealth.

NJ S839

Revises reimbursement payments for providers using telemedicine and telehealth.

NJ S3947

Extends permanently certain pay parity regarding telemedicine and telehealth.

SC S0377

Telemedicine and telehealth

MT SB438

Revise telehealth and telemedicine laws

NJ A1645

Clarifies that veterinarians are not within ambit of telemedicine and telehealth law.

NJ S1935

Revises emergency care services referral standards for providers of telemedicine and telehealth.

NJ A1499

Codifies certain requirements and stipulations for licensed veterinarians to engage in telemedicine and telehealth.

SC H4335

Telehealth and telemedicine providers

NJ A4957

Authorizes prescription of Schedule II controlled dangerous substances through telemedicine or telehealth without certain in-person requirements.

Similar Bills

NJ S1935

Revises emergency care services referral standards for providers of telemedicine and telehealth.

NJ A1645

Clarifies that veterinarians are not within ambit of telemedicine and telehealth law.

NJ A4852

Permits prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.

NJ A4957

Authorizes prescription of Schedule II controlled dangerous substances through telemedicine or telehealth without certain in-person requirements.

NJ S4210

Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.

NJ A1499

Codifies certain requirements and stipulations for licensed veterinarians to engage in telemedicine and telehealth.

NJ A2009

Expressly allows health care professionals located outside New Jersey to provide services using telemedicine and telehealth to patients in New Jersey.

NJ S1629

Expressly allows health care professionals located outside New Jersey to provide services using telemedicine and telehealth to patients in New Jersey.